Twenty-Eight Years of Poliovirus Replication in an Immunodeficient Individual: Impact on the Global Polio Eradication Initiative
Open accessThe DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
There are currently huge efforts by the World Health Organization and partners to complete global polio eradication. With the significant decline in poliomyelitis cases due to wild poliovirus in recent years, rare cases related to the use of live-attenuated oral polio vaccine assume greater importance. Poliovirus strains in the oral vaccine are known to quickly revert to neurovirulent phenotype following replication in humans after immunisation. These strains can transmit from person to person leading to poliomyelitis outbreaks and can replicate for long periods of time in immunodeficient individuals leading to paralysis or chronic infection, with currently no effective treatment to stop excretion from these patients. Here, we describe an individual who has been excreting type 2 vaccine-derived poliovirus for twenty eight years as estimated by the molecular clock established with VP1 capsid gene nucleotide sequences of serial isolates. This represents by far the longest period of excretion described from such a patient who is the only identified individual known to be excreting highly evolved vaccine-derived poliovirus at present. Using a range of in vivo and in vitro assays we show that the viruses are very virulent, antigenically drifted and excreted at high titre suggesting that such chronic excreters pose an obvious risk to the eradication programme. Our results in virus neutralization assays with human sera and immunisation-challenge experiments using transgenic mice expressing the human poliovirus receptor indicate that while maintaining high immunisation coverage will likely confer protection against paralytic disease caused by these viruses, significant changes in immunisation strategies might be required to effectively stop their occurrence and potential widespread transmission. Eventually, new stable live-attenuated polio vaccines with no risk of reversion might be required to respond to any poliovirus isolation in the post-eradication era.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Virus attenuation by genome-scale changes in codon pair bias
Coleman, J. R., Papamichail, D., Skiena, S., Futcher, B., Wimmer, E., & Mueller, S. (2008) · Science · doi:10.1126/science.1155761 · Cited by 715
Kew, O., Morris-Glasgow, V., Landaverde, M., Burns, C., Shaw, J., Garib, Z., André, J., Blackman, E., Freeman, C. J., Jorba, J., et al. (2002) · Science · doi:10.1126/science.1068284 · Cited by 600 · cited 1×
“6% for serotype 2 poliovirus) sequence drift in the capsid VP1 gene with respect to the corresponding Sabin strain, can be generated and transmitted from person to person in populations with low immunity and have been associated with a number of poliomyelitis outbreaks around the world [5–9].”
BackgroundRole of environmental poliovirus surveillance in global polio eradication and beyond
HOVI, T., SHULMAN, L. M., VAN DER AVOORT, H., DESHPANDE, J., ROIVAINEN, M., & DE GOURVILLE, E. M. (2012) · Epidemiology and Infection · doi:10.1017/s095026881000316x · Cited by 318 · cited 6×
“Israel, which also switched from OPV to IPV at a similar date (2005), has recently detected the widespread circulation of type 1 wild poliovirus through environmental surveillance.”
BackgroundInfluentialPlatt, L. R., Estivariz, C. F., & Sutter, R. W. (2014) · Journal of Infectious Diseases · doi:10.1093/infdis/jiu184 · Cited by 267 · cited 1×
“Vaccine-associated paralytic poliomyelitis occurs in a very small proportion of vaccinees [4] and can be prevented by using inactivated rather than live vaccine.”
BackgroundFine, P. E. M., & Carneiro, I. A. M. (1999) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009924 · Cited by 247
Prolonged replication of a type 1 vaccine-derived poliovirus in an immunodeficient patient
Kew, O. M., Sutter, R. W., Nottay, B. K., McDonough, M. J., Prevots, D. R., Quick, L., & Pallansch, M. A. (1998) · Journal of Clinical Microbiology · doi:10.1128/jcm.36.10.2893-2899.1998 · Cited by 213 · cited 1×
“In addition, some hypogammaglobulinaemic patients are known to excrete poliovirus for prolonged periods of time [10–12] but there is currently no effective strategy to deal with this problem.”
BackgroundCalibration of multiple poliovirus molecular clocks covering an extended evolutionary range
Jorba, J., Campagnoli, R., De, L., & Kew, O. (2008) · Journal of Virology · doi:10.1128/jvi.02354-07 · Cited by 177
Burns, C. C., Campagnoli, R., Shaw, J., Vincent, A., Jorba, J., & Kew, O. (2009) · Journal of Virology · doi:10.1128/jvi.00508-09 · Cited by 170
Martín, J., Dunn, G., Hull, R., Patel, V., & Minor, P. D. (2000) · Journal of Virology · doi:10.1128/jvi.74.7.3001-3010.2000 · Cited by 160 · cited 1×
“In addition, some hypogammaglobulinaemic patients are known to excrete poliovirus for prolonged periods of time [10–12] but there is currently no effective strategy to deal with this problem.”
BackgroundSelf-citationBurns, C. C., Shaw, J., Jorba, J., Bukbuk, D., Adu, F., Gumede, N., Pate, M. A., Abanida, E. A., Gasasira, A., Iber, J., et al. (2013) · Journal of Virology · doi:10.1128/jvi.02954-12 · Cited by 153 · cited 1×
“6% for serotype 2 poliovirus) sequence drift in the capsid VP1 gene with respect to the corresponding Sabin strain, can be generated and transmitted from person to person in populations with low immunity and have been associated with a number of poliomyelitis outbreaks around the world [5–9].”
Background
Cited by
Baang, J. H., Smith, C., Mirabelli, C., Valesano, A. L., Manthei, D. M., Bachman, M. A., Wobus, C. E., Adams, M., Washer, L., Martin, E. T., et al. (2021) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa666 · Cited by 307
Recommendations for enterovirus diagnostics and characterisation within and beyond Europe
Harvala, H., Broberg, E., Benschop, K., Berginc, N., Ladhani, S., Susi, P., Christiansen, C., McKenna, J., Allen, D., Makiello, P., et al. (2018) · Journal of Clinical Virology · doi:10.1016/j.jcv.2018.01.008 · Cited by 258
Self-citationDiagnostic Assay Development for Poliovirus Eradication
Gerloff, N., Sun, H., Mandelbaum, M., Maher, C., Nix, W. A., Zaidi, S., Shaukat, S., Seakamela, L., Nalavade, U. P., Sharma, D. K., et al. (2018) · Journal of Clinical Microbiology · doi:10.1128/jcm.01624-17 · Cited by 72
“Challenges that remain to be addressed include improving PanPV performance, identifying iVDPV2 from highly diverged polioviruses from immunocompromised persons (15), and increasing the sensitivity of the assays for the eventual detection of viral genome in RNA extracted directly from stool or concentrated sewage.”
BackgroundBahar, M. W., Porta, C., Fox, H., Macadam, A. J., Fry, E. E., & Stuart, D. I. (2021) · npj Vaccines · doi:10.1038/s41541-020-00267-3 · Cited by 42
Macklin, G., Liao, Y., Takane, M., Dooling, K., Gilmour, S., Mach, O., Kew, O. M., Sutter, R. W., & The iVDPV Working Group (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01103 · Cited by 47
Metadata
- Authors
- Dunn, G., Klapsa, D., Wilton, T., Stone, L., Minor, P. D., & Martin, J.
- Venue
- PLOS Pathogens
- Publisher
- Public Library of Science (PLoS)
- Published
- 2015-08-27
- Volume
- 11
- Issue
- 8
- Pages
- e1005114
- ISSN
- 1553-7366 (ISSN-L)
- 1553-7374
- OpenAlex
- W1659618301
- Cited by
- 106
- References
- 14
- FWCI
- 10.26
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Twenty-Eight Years of Poliovirus Replication in an Immunodeficient Individual: Impact on the Global Polio Eradication Initiative. https://app.cochat.ai/papers/10.1371/journal.ppat.1005114
- The paper
- Dunn, G., Klapsa, D., Wilton, T., Stone, L., Minor, P. D., & Martin, J. (2015). Twenty-Eight Years of Poliovirus Replication in an Immunodeficient Individual: Impact on the Global Polio Eradication Initiative. PLOS Pathogens. https://doi.org/10.1371/journal.ppat.1005114
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.